Participants:18–64 years · 65+ years
Substances:4-[3-(Cyanomethyl)-3-(3',5'-Dimethyl-1H,1'H-[4,4'-Bipyrazol]-1-Yl)Azetidin-1-Yl]-2,5-Difluoro-N-[(2S)-1,1,1-Trifluoropropan-2-Yl]Benzamide

Contact Research Centre

Asthma

Not recruiting

Registered drugNo placebo

Study on the Effects of Mepolizumab for Achieving Clinical Remission in Patients with Severe Asthma

Registered drugNo placebo

France

Participants:18–64 years · 65+ years
Substances:Mepolizumab

Contact Research Centre

Diffuse large B-cell lymphoma

Not recruiting

Registered drug

Study on Acalabrutinib with Drug Combination for Patients 75 and Older with Untreated Diffuse Large B-Cell Lymphoma

Registered drug

France

Participants:18–64 years · 65+ years
Substances:Acalabrutinib

Contact Research Centre

Non-small cell lung cancer+2

Not recruiting

Registered drug

Study on Tiragolumab and Atezolizumab for Patients with Resected Stage IIB-IIIB Non-Small Cell Lung Cancer After Chemotherapy

Registered drug

France

Participants:18–64 years · 65+ years

Contact Research Centre

Mantle cell lymphoma

Not recruiting

Registered drugNo placebo

Study on Ibrutinib, CD20 Ab and Venetoclax for Patients with Untreated Mantle Cell Lymphoma

Registered drugNo placebo

France

Participants:18–64 years · 65+ years
Substances:Ibrutinib

Contact Research Centre

Chronic lymphocytic leukaemia

Not recruiting

Registered drugNo placebo

Study of Acalabrutinib for Patients with Chronic Lymphocytic Leukemia

Registered drugNo placebo

France

Participants:18–64 years · 65+ years
Substances:Acalabrutinib

Contact Research Centre

Mantle cell lymphoma

Not recruiting

Registered drugNo placebo

Study of Zanubrutinib and Rituximab Compared to Bendamustine and Rituximab for Patients with Untreated Mantle Cell Lymphoma Ineligible for Stem Cell Transplant

Registered drugNo placebo

France

Participants:18–64 years · 65+ years
Substances:Rituximab

Contact Research Centre

Bronchiectasis

Not recruiting

Investigational

Study on the Effects of Itepekimab for Patients with Non-Cystic Fibrosis Bronchiectasis

Investigational

France

Participants:18–64 years · 65+ years
Substances:Itepekimab

Contact Research Centre

Von Willebrand's disease

Not recruiting

Registered drugNo placebo

Study on the Effectiveness and Safety of Vonicog Alfa with or without Octocog Alfa for Children with Severe von Willebrand Disease Experiencing Bleeding or Undergoing Surgery

Registered drugNo placebo

France

Participants:0–17 years
Substances:Octocog Alfa

Contact Research Centre

Find therapies in clinical trials near you – page 42

584 trials match your criteria

Adenocarcinoma gastric+1

Study of Zolbetuximab Alone and with Drug Combination for Patients with Advanced Stomach or Gastroesophageal Junction Cancer

Non-obstructive cardiomyopathy

Study on Mavacamten for Adults with Non-obstructive Hypertrophic Cardiomyopathy

Myelofibrosis

Study Comparing Fedratinib with Drug Combination for Myelofibrosis in Patients Previously Treated with Ruxolitinib

Hidradenitis

Study on the Long-Term Safety of Povorcitinib for Patients with Moderate to Severe Hidradenitis Suppurativa

Asthma

Study on the Effects of Mepolizumab for Achieving Clinical Remission in Patients with Severe Asthma

Diffuse large B-cell lymphoma

Study on Acalabrutinib with Drug Combination for Patients 75 and Older with Untreated Diffuse Large B-Cell Lymphoma

Non-small cell lung cancer+2

Study on Tiragolumab and Atezolizumab for Patients with Resected Stage IIB-IIIB Non-Small Cell Lung Cancer After Chemotherapy

Mantle cell lymphoma

Study on Ibrutinib, CD20 Ab and Venetoclax for Patients with Untreated Mantle Cell Lymphoma

Chronic lymphocytic leukaemia

Study of Acalabrutinib for Patients with Chronic Lymphocytic Leukemia

Mantle cell lymphoma

Study of Zanubrutinib and Rituximab Compared to Bendamustine and Rituximab for Patients with Untreated Mantle Cell Lymphoma Ineligible for Stem Cell Transplant

Bronchiectasis

Study on the Effects of Itepekimab for Patients with Non-Cystic Fibrosis Bronchiectasis

Von Willebrand's disease

Study on the Effectiveness and Safety of Vonicog Alfa with or without Octocog Alfa for Children with Severe von Willebrand Disease Experiencing Bleeding or Undergoing Surgery

Explore other searches

Vaccine trials

Paediatric trials · ages 0–17

Healthy volunteers

Helpful resources

How applying through us works

What happens after you apply

Guides for patients and volunteers

Search filters

Prefer not to search? Our Concierge searches the trials for you.